Unknown

Dataset Information

Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.


ABSTRACT:

Background

Accurate diagnostic biomarker testing is crucial to treatment decisions in breast cancer. Biomarker testing is performed on core needle biopsies (CNB) and is often repeated in the surgical specimen (SS) after resection. As differences between CNB and SS testing may alter treatment decisions, we evaluated concordance between CNB and SS as well as associated changes in treatment and clinical outcomes.

Methods

We performed a retrospective analysis of breast cancer patients at our institution between January 2010 and May 2020. Concordance between CNB and SS was assessed for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Survival in pati

SUBMITTER: Slostad JA 

PROVIDER: S-EPMC9761085 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature